LGC launches SARS-CoV-2 quality solution for antigen testing

News - Formulated for use with test methods that detect nucleocapsid protein of SARS-CoV-2 virus

01 April 2021

TNAC wins Best COVID-19 Responder award

News - Awarded for efforts in supporting research and development of diagnostics and vaccines for COVID-19

21 June 2021

Measurement science improves standardisation of SARS-CoV-2 quantification

News - NML team analysis vital to understanding potential discrepancies in measured viral burden used to manage CoVid-19 pandemic

12 October 2021

LGC Clinical Diagnostics extend collaboration with Stanford Medicine supporting global genetic and metabolomic diagnostic testing

News - The exclusive partnership will also be extended to include the analysis of phenotypic-genotypic correlations and metabolic profiling of some common maternal/ fetal cardiac defects known to be related to monogenic disorders.

02 August 2022

LGC’s new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research

News - Facility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies

16 September 2022

LGC acquires Kova International, Inc., including Biochemical Diagnostics, Inc., strengthening its portfolio of Quality Measurement Tools

News - Today, LGC Clinical Diagnostics, a business unit of LGC, announced the acquisition of Kova International, Inc. (Kova), a leading developer and manufacturer of in vitro urinalysis and toxicology quality control products for clinical laboratories

24 July 2023

LGC acquires Virusys Corporation.

News - LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.

09 October 2023